PRS-352

N/A

Report date: 2024/12/19 10:48:56

Base Information

Drug NamePRS-352
Drug Alias NamePRS-352S-095025
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunomodulatorsT lymphocytes stimulantsTumor necrosis factor receptor superfamily member 4 agonists +[4] 
TargetsTumor necrosis factor receptor superfamily member 4Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPieris Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPieris PharmaceuticalsLaboratoires Servier
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A